STAT

NOVEMBER 9, 2023

MEXICO CITY — More than 5.6 million U.S. tourists head to Cancun every year, drawn to the Mexican port’s white sand beaches, all-inclusive resorts, and raucous nightlife. Soon there’s likely to be another reason to visit: MSI Reproductive Choices , an international reproductive health nonprofit, plans to open an abortion clinic in the city, partly designed to cater to travelers from the U.S. who are unable to get an abortion in their home states.

362

362

PharmaVoice

NOVEMBER 9, 2023

A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics can mute sickle cell disease’s most damaging symptoms. Yet treatment may not be as simple as its dramatic benefit makes it seem.

246

246

STAT

NOVEMBER 9, 2023

A panel of government advisers finally has endorsed ideas for Congress to solve the particularly thorny problem of surprise ambulance bills , including a cap on how much patients would have to pay if they took an ambulance. Surprise bills have been eliminated for most health care services, but people who take out-of-network ground ambulances remain broadly unprotected — facing potentially thousands of dollars and the threat of collections for a ride that nobody really asks for.

Hospitals 343

Hospitals 343

PharmaVoice

NOVEMBER 9, 2023

The maze of ethical issues in biopharma can confound even the wiliest executive. How do some leaders get by?

148

148

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 9, 2023

In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.

338

338

PharmaVoice

NOVEMBER 9, 2023

With its long-time CEO on the way out, the rare disease biotech has seen an activist investor grow its stake.

130

130

The Pharmacist

NOVEMBER 9, 2023

The chief executive of NHS England (NHSE), Amanda Pritchard, will be called before the Health and Social Care Committee’s (HSCC) pharmacy inquiry, which is expected to begin later this month. The inquiry is set to look at the Additional Roles Reimbursement Scheme (ARRS), workforce issues, proposed legislative changes to pharmacy supervision and hub and spoke […] The post Pharmacy inquiry will question NHSE chief exec appeared first on The Pharmacist.

115

115

STAT

NOVEMBER 9, 2023

Maybe probiotics would have saved my son’s life. I’ll never know because when I asked Micah’s care team to consider probiotics to counter the deluge of antibiotics, I was dismissed as senseless. My son Micah was born at 27 weeks gestation, weighing just over 2 pounds, with a head full of thick, wavy hair. By 6 weeks old, Micah weighed 5 pounds, was beginning to nurse, and was progressing toward discharge.

331

331

The Pharmacist

NOVEMBER 9, 2023

A fresh call has been made for a nationally commissioned non-referral smoking cessation service through community pharmacies, as the government announces major investment in local schemes. In the King’s Speech this week, it was revealed that the funding available to local smoking cessation services would ‘more than double’ by next April to £140m, while plans […] The post Renewed call for national non-referral smoking cessation service appeared first on The Pharmacist.

Community Pharmacies 121

Community Pharmacies 121

STAT

NOVEMBER 9, 2023

When Jason Farley was growing up in rural Alabama as a young gay man, he faced a lot of prejudice. “Everything I heard was like I was going to wake up one day and God was going to smite me with AIDS,” he said.

322

322

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders. In July 2023, MyMD Pharmaceuticals released results from its Phase II study in sarcopenia evaluating potential of MYMD-1 ® , its first-in-class oral TNF-α inhibitor.

Drug Development 106

Drug Development Immunity Immunization Pharmaceutical Companies 106

STAT

NOVEMBER 9, 2023

Apple has for years promised that its devices can help people live healthier, but it has so far produced little concrete evidence of this benefit. Many of the company’s health tools are consumer features without strong ties to the health care system, so there often isn’t a health care outcome to measure as proof. Nevertheless, Apple has embarked on several systematic studies exploring how its devices might be used to more directly improve health conditions, and after several years,

313

313

Pharma Times

NOVEMBER 9, 2023

The WID-qEC test successfully identified 91% of womb cancer cases - News - PharmaTimes

143

143

STAT

NOVEMBER 9, 2023

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them.

241

241

European Pharmaceutical Review

NOVEMBER 9, 2023

Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing 105

STAT

NOVEMBER 9, 2023

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. And then there were five (well, six) A pared-back field of five GOP presidential candidates sparred Wednesday night, touching on health issues ranging from hot-button election topics, to wonky budget math.

Diabetes 205

Diabetes Hospitals 205

World Pharma News

NOVEMBER 9, 2023

Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder.

97

97

STAT

NOVEMBER 9, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a counterintuitive idea in pharma, an ode to scientific matrimony, and the solution to a CAR-T mystery.

187

187

The Pharmacist

NOVEMBER 9, 2023

Figures revealing NHS England’s spending on medicines highlight the ‘vital’ role of pharmacists in medicines optimisation, the chair of the Royal Pharmaceutical Society (RPS) in England has said. Figures released by the NHS Business Services Authority (NHSBSA) today reveal that in 2022/23, NHSE spent £9.59bn on medicines prescribed in primary care and dispensed in the […] The post NHSE prescribing costs highlight ‘vital’ role of pharmacists appeared first on The Pharmacist.

92

92

Express Pharma

NOVEMBER 9, 2023

USV and Biogenomics announced the launch of INSUQUICK, biosimilar Insulin Aspart. A company statement informed, “InsuQuick is a “Make in India” product, developed and manufactured using 100 per cent indigenous technology, and has undergone a robust clinical program to ensure global quality standards. It is available in all metros, and Tier I/II cities.

Biosimilars 98

Biosimilars Diabetes 98

Pharma Times

NOVEMBER 9, 2023

The campaign was first launched to coincide with the 75th anniversary of the NHS - News - PharmaTimes

117

117

BioPharma Dive

NOVEMBER 9, 2023

Shares in the biotech tumbled by 75% as results from a Phase 2 trial showed more improvement in participants given a placebo.

109

109

Eye on FDA

NOVEMBER 9, 2023

While enforcement has been at a low ebb for quite some time with FDA’s Office of Prescription Drug Promotion (OPDP), this week took a different turn with the posting of two new untitled letters sent October 31. That brings the total number of letters issued by OPDP to five this year – one Warning Letter that came out in August respecting a sales aid used in promoting a treatment for COPD, and 4 untitled letters – one in June, one in August, and now two in October.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies 88

Pharmaceutical Technology

NOVEMBER 9, 2023

GlobalData analyst Jemima Walker discusses key topics around cloud computing for the pharmaceutical industry.

114

114

The Script

NOVEMBER 9, 2023

Gen Z is reshaping the field of pharmacy with tech-savviness, adaptability, and patient-centered care. Rx relief explains more.

Pharmacy Management 105

Pharmacy Management 105

European Pharmaceutical Review

NOVEMBER 9, 2023

Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. In this issue, Peter Stenico, Biosimilar Global Platform Head at Sandoz, highlights how emerging technology platforms such as nanobodies, ADCs and cell and gene therapies are “on course to revolutionise medicine,” with significant growth anticipated over the next decade.

Biosimilars 83

Biosimilars Drug Development 83

The Pharmacist

NOVEMBER 9, 2023

NICE has recommended the use of ‘game changer’ wearable technology to help patients manage type 1 diabetes. Hybrid closed loop systems allow insulin to be delivered automatically to the body, keeping blood glucose at a healthy level. This technology includes a continuous glucose monitor sensor which transmits data to an insulin pump, both of which […] The post NICE recommends ‘game changer’ wearable tech for type 1 diabetes appeared first on The Pharmacist.

Diabetes 71

Diabetes 71

PharmExec

NOVEMBER 9, 2023

Solomon discusses new ways that researchers are fighting against bacterial resistance to medications.

105

105

pharmaphorum

NOVEMBER 9, 2023

Medicine, Media, Metamorphosis: How M3 is championing medical communications for modern healthcare Mike.

Communication 100

Communication 100

PharmExec

NOVEMBER 9, 2023

A look into the potential effect of psychedelic drugs on various illnesses, such as mental health conditions.

98

98

Welltopia Pharmacy

NOVEMBER 9, 2023

Vitamins for Healthy Teeth and Bones: Importance of dental and skeletal health, Oral hygiene: Good dental health prevents tooth decay.

79

79

PharmExec

NOVEMBER 9, 2023

Healthy Food Rx provides home-delivered medical prescriptions of healthy food to help address diabetes.

Diabetes 97

Diabetes 97

Fuld & Company Blog

NOVEMBER 9, 2023

Mike Ratcliffe , Senior Director at Fuld, recently sat down in conversation with leading War Game expert, Professor Leonard Lane from the Paul Merage Business School , University of California, Irvine , to explore how businesses can leverage war gaming to thrive in an ever-changing, complex, and competitive business environment. Fuld has been working with the school for over 15 years, successfully developing the concept of War Games and running workshops with the school’s business students

64

64

pharmaphorum

NOVEMBER 9, 2023

Takeda bags FDA okay for Fruzaqla in colorectal cancer Phil.

104

104

Drug Patent Watch

NOVEMBER 9, 2023

Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen… The post New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

59

59